Scientists test speed of new insulin in chinese patients
NCT ID NCT04698018
Summary
This study measured how quickly a new, faster-acting insulin gets into the bloodstream compared to a standard insulin. It involved 23 Chinese adults with type 1 or type 2 diabetes. Each participant received one injection of each insulin type, and researchers took frequent blood samples to track the speed and amount of insulin in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Phase 1 Clinical Trial Centre
Shatin, New Territories, Hong Kong, Postal Code: NA, Hong Kong
-
Phase 1 Clinical Trial Centre
Shatin, New Territories, Hong Kong
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.